At the core of the initiative is the CL1 biological computer developed by Cortical Labs, an Australian biotechnology company.

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...

Access to biologic therapy, such as omalizumab, is a significant barrier for CSU patients in Latin America, despite high disease knowledge. Participants in the pilot program had high baseline ...

After infection with the SARS-CoV-2 virus, up to ten percent of those affected in Germany develop Long COVID. The symptoms ...

The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.

When approached with intention, diagnostic pathology shifts fear into understanding, apprehension into purpose, and leaves a lasting mark on how a veterinarian approaches medicine and their role ...

The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...

Chronic inflammation may be quietly reshaping the colon and making it more vulnerable to early-onset colorectal cancer. Scientists found that colon tissue in younger patients was stiffer, even in ...

A new study suggests that long-term inflammation may physically change the colon in ways that promote early-onset colorectal cancer (CRC). Researchers ...

SynaXG, a global innovator in AI-driven radio access network platforms, today announced a technology partnership of its AI-RAN platform, where the companies served as the Catalyst project AURA (AI-RAN ...

TFOS DEWS III emphasizes matching dry eye treatments to specific mechanisms such as lipid imbalance, osmolarity, and glycocalyx failure.

Aims The obesity paradox has been described in different cardiovascular conditions. Data on the association between obesity and outcomes in patients with Takotsubo syndrome (TTS) are lacking. The aim ...